Is the U.S. really slower than Europe in approving new drugs?
Thu, 17 Mar 2011 08:21:00 -0500
FDA answers this question with a series of charts and graphs that show that, on average, FDA has approved more novel new drugs, has approved these drugs more quickly, and has enabled these drugs to come to market sooner than has its European counterpart, the European Medicines Agency (EMA).
Subscriber Services:
Manage Preferences | Unsubscribe | Help with this service
Stay Connected: | |||||||||||||
U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420